Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DNA sequencer output.

Large national genomic programmes have been created globally, including in many European countries like France, England and Germany, to advance the realisation of the potential genomic medicine holds to promote health and prevent disease as well as to drive industry and economic growth. The successful achievement of this aim requires the development of common approaches, not only to standardisation of the new technologies, but also to ethical standards in research and practice. Such standards are of particular importance where national genomic programmes (e.g. Genomics England, the Plan France Médecine Génomique 2025, or the German genomeDE) are developed within publicly funded solidarity-based health systems that require the equitable return of benefits of these programmes to society as a whole.

UK-FR-D+ GENE (Genomics and Ethics Network) provides a platform for researchers and other relevant stakeholders (e.g. clinicians and policy makers) from the UK, France, Germany, but also other European and extra-European countries, to reflect on the ethical and social questions of genomic technologies and their clinical application that emerge in different national contexts but also across nations. To gain an in-depth understanding of the social and ethical issues at stake, we propose a comparative perspective that sheds new light on these issues and offers potential solutions that are context sensitive. UK-FR-D+ GENE creates an opportunity to develop joint research agendas and collaborations that aim to inform ethical standards in the use of genomic technologies in clinical practice across Europe. The network was launched in 2018 by Ruth Horn and Marie Gaille, and is coordinated today by Ruth Horn and Jennifer Merchant.

If you are interested in the network, whether you are from the UK, France, Germany or any other country, and would like to be informed about our activities, please get in touch with Ruth Horn.

Coordinators

  • Ruth Horn (Ethox Centre, Wellcome Centre for Ethics and Humanities, Oxford; Ethics of Medicine, Augsburg)
  • Jennifer Merchant (University Paris 2)

Steering Committee

Activities

Outputs

  • Horn, R., Kerasidou, A., Merchant, J. et al. The value of large-scale programmes in human genomics. Eur J Hum Genet (2025). https://doi.org/10.1038/s41431-025-01844-7
  • Horn, R., Merchant, J. & The UK-FR+GENE (Genetics and Ethics Network) Consortium. Ethical and social implications of public–private partnerships in the context of genomic/big health data collection. Eur J Hum Genet (2024). https://doi.org/10.1038/s41431-024-01608-9
  • Horn, R., Merchant, J. & The UK-FR GENE Consortium. Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison. Eur J Hum Genet (2022). https://doi.org/10.1038/s41431-022-01247-y
  • Gaille, M., Horn, R. & The UK-FR GENE (Genetics and Ethics Network) Consortia. The ethics of genomic medicine: redefining values and norms in the UK and France. Eur J Hum Genet 29, 780–788 (2021). https://doi.org/10.1038/s41431-020-00798-2

UK-FR GENE Group Meeting November 2022

UK-FR GENE Workshop, 23 November 2022

Title Image courtesy of National Human Genome Research Institute